Relapse prevention in pediatric patients with ADHD treated with atomoxetine: A randomized, double-blind, placebo-controlled study

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 43, Issue 7, 2004, Pages 896-904

  Michelson, David ^a   Buitelaar, Jan K ^b   Danckaerts, Marina ^c   Gillberg, Christopher ^d   Spencer, Thomas J ^e   Zuddas, Alessandro ^f   Faries, Douglas E ^a   Zhang, Shuyu ^a   Biederman, Joseph ^e  

^a ELI LILLY AND COMPANY   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d Drottning Silvias Barn Och Ungdomssjukhus   (Sweden)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Atomoxetine; Attention deficit hyperactivity disorder; Pediatric patients; Relapse prevention

Indexed keywords

ATOMOXETINE; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD PSYCHIATRY; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; SCHOOL CHILD; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 3042559692     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000125089.35109.81     Document Type: Article

References (29)

1. American Psychiatric Association (2000), Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Press
2. Andres Carrasco MA, Catala MA, Gomez-Beneyto M (1995), Study of the prevalence of the attention deficit hyperactivity disorder in ten-year-old children living in the Valencia metropolitan area [in Spanish]. Actas Luso Esp Neurol Psiquiatr Ciene Afines 23:184-188
3. Biederman J, Faraone S, Monuteaux MC, Grossbard J (in press), How informative are parent reports of ADHD symptoms for assessing outcome in clinical trials? A pooled analysis of parents' and teachers' reports. Pediatrics.
4. Conners CK (1997), Conners' Rating Scales-Revised. North Tonawanda, NY: Multi-Health Systems
5. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998), ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations. New York: Guilford
6. Gillberg C, Melander H, von Knorring AL et al. (1997), Long-term stimulant treatment of children with artention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 54:857-864
7. Graetz BW, Sawyer MG, Hazell PL, Arney F, Baghurst P (2001), Validity of DSM-IV ADHD subtypes in a nationally representative sample of Australian children and adolescents. J Am Acad Child Adolesc Psychiatry 40:1410-1417
8. Kadesjo B, Gillberg C (2001), The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiatry 42:487-492
9. Kaufman J, Birmaher B, Brent D, Rao U, Ryan N (1996), Kiddie-SADS-Present and Lifetime Version (K-SADS-PL). Pittsburgh: Department of Psychiatry, University of Pittsburgh School of Medicine
10. Kratochvil CJ, Heiligenstein JH, Dittman R et al. (2002), Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry 41:776-784
11. Landgraf JM, Abetz L, Ware JE (1996), The CHQ User's Manual. First Edition. Boston: The Health Institute, New England Medical Center
12. Loeber R, Green SM, Lahey BB, Stouthamer-Loeber M (1991), Differences and similarities between children, mothers, and teachers as informants on disruptive child behavior. J Abnorm Child Psychol 19:75-95
13. March JS, Sullivan K (1999), Test-retest reliability of the multidimensional anxiety scale for children. J Anxiety Disord 13:349-358
14. Michelson D (2002), Treatment of ADHD: beyond stimulants. Presented at the 15th European Neuropsychopharmacology Congress, Barcelona, Spain, October
15. Michelson D, Adler L, Spencer T et al. (2003), Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53:112-120
16. Michelson D, Allen AJ, Busner J et al. (2002a), Once-daily atomoxetine treatment for children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159:1896-1901
17. Michelson D, Faries D, Wernicke J et al. (2001), Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108:e83
18. Michelson D, Gao H, Allen AJ, Witcher J (2002b), Plasma atomoxetine concentration and response to ADHD in children and adolescents. Presented at the 42nd Annual Meeting of the New Clinical Drug Evaluation Unit, Boca Raton, FL, June
19. Miller A (1999), Appropriateness of psychostimulant prescription to children: theoretical and empirical perspectives. Can J Psychiatry 44:1017-1024
20. Mitsis EM, McKay KE, Schulz K, Newcorn J, Halperin JM (2003), Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry 39:308-313
21. MTA Cooperative Group (1999), A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086
22. Newcorn J (2002), Efficacy trials of atomoxetine for ADHD in children, adolescents and adults. Presented at the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, October
23. Oosterlaan J, Sergeant JA (2003), Inhibition in ADHD, aggressive, and anxious children: a biologically based model of child psychopathology. J Abnorm Child Psychol 24:19-36
24. Poznanski EO, Mokros HB (1999), Children's Depression Rating Scale (CDRS-R) Revised. Los Angeles: Western Psychological Services
25. Sergeant J, Steinhausen HC (1992), European perspectives on hyperkinetic disorder. Eur Child Adolesc Psychiatry 1:34-41
26. Spencer T, Heiligenstein JH, Biederman J et al. (2002), Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63:1140-1147
27. Spencer TJ, Biederman J, Harding M, O'Donnell D, Faraone SV, Wilens TE (1996), Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 35:1460-1469
28. Spreen O (1998), A Compendium of Neuropsychological Tests, 2nd Edition: Administration, Norms, and Commentary. Oxford: Oxford University Press
29. Wechsler D (1991), Wechsler Intelligence Scale for Children (WISC-III). San Antonio, TX: The Psychological Corporation